Page 6 of 9
The table below shows the number of patients (percent) with adverse events of special
interest reported during the on-treatment period.
Number of patients (percent) with adverse events of special interest
reported during the on-treatment period
Belimumab Placebo
2002 patients 2001 patients
Serious infections 75 (4%) 82 (4%)
Other infections 36 (2%) 50 (2%)
Thoughts of committing suicide as
28 (1%) 23 (1%)
assessed using a suicidality scoring scale
Allergic reactions to the study medicine 8 (less than 1%) 2 (less than 1%)
Serious depression 7 (less than 1%) 1 (less than 1%)
Cancer other than of the skin 5 (less than 1%) 5 (less than 1%)
Skin cancer 4 (less than 1%) 3 (less than 1%)
What were the side effects?
If the study doctor thinks that an adverse event was caused by the study medicine,
they record this as a possible side effect (adverse reaction).
Difference between adverse events and side effects in this summary